Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemoglobin in the Cerebrospinal Fluid to Monitor for Secondary Brain Injury After Aneurysmal Subarachnoid Hemorrhage - a Prospective Multinational Validation Study

NCT04998370 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT04998370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04998370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemoglobin in the Cerebrospinal Fluid to Monitor for Secondary Brain Injury After Aneurysmal Subarachnoid Hemorrhage - a Prospective Multinational Validation Study
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Completed
Start date
August 18, 2021
Completion date
October 1, 2024
Enrollment
366 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

delayed cerebral ischemia, delayed ischemic neurological deficit, subarachnoid hemorrhage, aneurysmal, vasospasm